Ray Elliott Retiring: Is Boston Scientific On Or Off Track?
Ray Elliott's surprise retirement announcement from Boston Scientific last week was to some a warning sign that the company's challenges are even bigger than expected, but the CEO argues it is just the opposite. He says he has accomplished what he came to do.
More from Archive
More from Medtech Insight
Medical devices, diagnostics, and equipment face tariffs announced by President Donald Trump, despite industry pleas for exemption. The tariffs, ranging from 10%-49%, impact most countries trading with the US, potentially hindering innovation and increasing costs in the medtech sector.
The US FDA has published its final document to guide sponsors on using sex-specific data in designing clinical trials of medical devices. However, the guidance removes all references to gender that appeared in January’s draft guidance, released before the Trump administration took office.